*The Role of the Receptor for Advanced Glycation Endproducts (RAGE) in Type 1 Diabetes… DOI: http://dx.doi.org/10.5772/intechopen.108528*

[85] Zirpel H, Roep BO. Islet-resident dendritic cells and macrophages in type 1 diabetes: In search of Bigfoot's print. Frontiers in Endocrinology. Lausanne. 2021;**12**:666795

[86] Wang YJ et al. Multiplexed In situ imaging mass cytometry analysis of the human endocrine pancreas and immune system in type 1 diabetes. Cell Metabolism. 2019;**29**(3):769-783.e4

[87] Hutchings P et al. Transfer of diabetes in mice prevented by blockade of adhesion-promoting receptor on macrophages. Nature. 1990;**348**(6302):639-642

[88] Nikolic T, Roep BO. Regulatory multitasking of tolerogenic dendritic cells - lessons taken from vitamin d3-treated tolerogenic dendritic cells. Frontiers in Immunology. 2013;**4**:113

[89] Nikolic T et al. Dendritic cells and macrophages are essential for the retention of lymphocytes in (peri) insulitis of the nonobese diabetic mouse: A phagocyte depletion study. Laboratory Investigation. 2005;**85**(4):487-501

[90] Jun HS et al. Absolute requirement of macrophages for the development and activation of beta-cell cytotoxic CD8+ T-cells in T-cell receptor transgenic NOD mice. Diabetes. 1999;**48**(1):34-42

[91] Soro-Paavonen A et al. Receptor for advanced glycation end products (RAGE) deficiency attenuates the development of atherosclerosis in diabetes. Diabetes. 2008;**57**(9):2461-2469

[92] Schmidt AM et al. The multiligand receptor RAGE as a progression factor amplifying immune and inflammatory responses. The Journal of Clinical Investigation. 2001;**108**(7):949-955

[93] Kanter JE, Hsu CC, Bornfeldt KE. Monocytes and macrophages as protagonists in vascular complications of diabetes. Frontiers in Cardiovascular Medicine. 2020;**7**:10

[94] Kawakami R et al. S100A9- RAGE Axis accelerates formation of macrophage-mediated extracellular vesicle microcalcification in diabetes mellitus. Arteriosclerosis, Thrombosis, and Vascular Biology. 2020;**40**(8):1838-1853

[95] Coughlan MT et al. RAGE-induced cytosolic ROS promote mitochondrial superoxide generation in diabetes. Journal of the American Society of Nephrology. 2009;**20**(4):742-752

[96] Zhou J et al. Intermittent hypoxia enhances THP-1 monocyte adhesion and chemotaxis and promotes M1 macrophage polarization via RAGE. BioMed Research International. 2018;**2018**:1650456

[97] Huber R et al. Tumour hypoxia promotes melanoma growth and metastasis via high mobility group Box-1 and M2-like macrophages. Scientific Reports. 2016;**6**(1):29914

[98] Miura J et al. AGE down-regulation of monocyte RAGE expression and its association with diabetic complications in type 1 diabetes. Journal of Diabetes and its Complications. 2004;**18**(1):53-59

[99] Rojas A et al. HMGB1 enhances the protumoral activities of M2 macrophages by a RAGE-dependent mechanism. Tumour Biology. 2016;**37**(3):3321-3329

[100] Hamilton-Williams EE et al. Beta cell MHC class I is a late requirement for diabetes. Proceedings of the National Academy of Sciences of the United States of America. 2003;**100**(11):6688-6693

[101] Markiewicz MA et al. RAE1ε ligand expressed on pancreatic islets recruits NKG2D receptor-expressing cytotoxic T cells independent of T cell receptor recognition. Immunity. 2012;**36**(1):132-141

[102] Chen Y, Liu Q , Guo D. Emerging coronaviruses: Genome structure, replication, and pathogenesis. Journal of Medical Virology. 2020;**92**(4):418-423

[103] Rojas A et al. Advanced-glycation end-products axis: A contributor to the risk of severe illness from COVID-19 in diabetes patients. World Journal of Diabetes. 2021;**12**(5):590-602

[104] Kim EJ et al. HMGB1 increases IL-1β production in vascular smooth muscle cells via NLRP3 Inflammasome. Frontiers in Physiology. 2018;**9**:313

[105] De Francesco EM, Vella V, Belfiore A. COVID-19 and diabetes: The importance of controlling RAGE. Frontiers in Endocrinology. 2020;**11**:526

[106] Uchida T et al. Receptor for advanced glycation end-products is a marker of type I cell injury in acute lung injury. American Journal of Respiratory and Critical Care Medicine. 2006;**173**(9):1008-1015

[107] Egana-Gorrono L et al. Receptor for advanced glycation end products (RAGE) and mechanisms and therapeutic opportunities in diabetes and cardiovascular disease: Insights from human subjects and animal models. Frontiers in Cardiovascular Medicine. 2020;**7**:37

[108] Sandooja R, Vura N, Morocco M. Heightened ACE activity and unfavorable consequences in COVID-19 diabetic subjects. International Journal of Endocrinology. 2020;**2020**:7847526

[109] Beliard K et al. Increased DKA at presentation among newly diagnosed type 1 diabetes patients with or without COVID-19: Data from a multi-site surveillance registry. Journal of Diabetes. 2021;**13**(3):270-272

[110] Gottesman BL et al. Incidence of new-onset type 1 diabetes among US children during the COVID-19 global pandemic. JAMA Pediatrics. 2022;**176**(4):414-415

[111] Dżygało K et al. Increased frequency of severe diabetic ketoacidosis at type 1 diabetes onset among children during COVID-19 pandemic lockdown: An observational cohort study. Pediatric Endocrinology Diabetes and Metabolism. 2020;**26**(4):167-175
